ShaadEssaAbedinMDFACP

PubMed

• Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study.
  Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo A Ascierto, Paul C Lorigan, Cornelia Mau...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 42 citations
  Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
  Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matt...> ;Nature Medicine. 2022 Nov 1
• 27 citations
  Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
  Richard D Carvajal, Paul Nathan, Joseph J Sacco, Marlana Orloff, Leonel F Hernandez-Aya, Jessica Yang, Jason J Luke, Marcus O Butler, Sarah Stanhope, Laura Collins, Ch...> ;Journal of Clinical Oncology. 2022 Jun 10
• 18 citations
  Resistance to durvalumab and durvalumab plus tremelimumab is associated with functional STK11 mutations in non-small-cell lung cancer patients and is reversed by STAT3...
  Nabendu Pore, Song Wu, Nathan Standifer, Maria Jure-Kunkel, Melissa de los Reyes, Yashaswi Shrestha, Rebecca A. Halpin, Raymond Rothstein, Kathy Mulgrew, Stephen Black...> ;Cancer Discovery. 2021 Jul 6
• 144 citations
  Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade
  Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu, Shaad Essa Abdullah, Brandon Higgs, Phillip A. Dennis, Michiel S. van der Heijden, Neil H. Segal, Jamie E. Ch...> ;Cancer Discovery. 2020 Aug 14
• 47 citations
  Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
  Guru Sonpavde, Juliane Manitz, Chen Gao, Darren Tayama, Constanze Kaiser, Daniel Hennessy, Doris Makari, Ashok K. Gupta, Shaad Essa Abdullah, Guenter Niegisch, Jonatha...> ;The Journal of Urology. 2020 Dec 1
• 10 citations
  Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escal...
  Peter H. O'Donnell, Hendrick Tobias Arkenau, Srikala S. Sridhar, Michael Ong, Alexandra Drakaki, Alexander I. Spira, Jingsong Zhang, Michael S. Gordon, Arnold Degboe, ...> ;Cancer. 2020 Jan 15
• 65 citations
  Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
  Scott J. Antonia, Ani Sarkis Balmanoukian, Julie R. Brahmer, Sai-Hong Ignatius Ou, Matthew D. Hellmann, Sang We Kim, Myung-Ju Ahn, Dong Wan Kim, Martin Gutierrez, Step...> ;Journal of Thoracic Oncology. 2019 Oct 1
• 61 citations
  Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
  Neil H. Segal, Sai-Hong Ignatius Ou, Ani Sarkis Balmanoukian, Matthew G. Fury, Erminia Massarelli, Julie R. Brahmer, Jared Weiss, Patrick Schöffski, Scott J. Antonia, ...> ;European Journal of Cancer. 2019 Mar 1
• 34 citations
  Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management
  Shaad E. Abdullah, Missak Haigentz, Bilal Piperdi> ;Chemotherapy Research and Practice. 2012 Sep 11
• 12 citations
  Hyalinizing clear cell carcinoma of the tonsil and its treatment
  Shadi B. Hijjawi, Shaad E. Abdullah, Kareem Abdelhadi, Eduardo Eyzaguirre, Maurice Willis, Nihal E. Abdulla> ;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2012 Aug 1
• 59 citations
  Mechanisms of resistance to vascular endothelial growth factor blockade
  Shaad E. Abdullah, Roman Perez-Soler> ;Cancer. 2012 Jul 15
• 27 citations
  The OnControl bone marrow biopsy technique is superior to the standard manual technique for hematologists-in-training: a prospective, randomized comparison.
  Louis Juden Reed, Radha Raghupathy, Marianna Strakhan, Thomas Philbeck, Mimi Y Kim, Ramakrishna Battini, Zulfiqar Hussain, Shaad E. Abdullah, Sarah J. Schweber, Kamale...> ;Hematology Reports. 2011 Oct 19
• 42 citations
  Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.
  Muralikrishna Gopal, Shaad E. Abdullah, James J. Grady, James S. Goodwin> ;Journal of Thoracic Oncology. 2010 Aug 1
• Join now to see all